Optimization of treatment of urolithiasis in patients with gout, complicated by nephropathy

Cover Page

Abstract


Aim: to improve the treatment of urolithiasis in patients with gout, complicated nephropathy. 68 patients with urate urolithiasis and gout complicated nephropathy, including 24 women and 44 men aged from 42 to 88 years, mean age 61 ± 8.7 years were examined. Duration of illness ranged from 2 to 28 years, mean 11.7 ± 5.1 years. All patients were treated by Trometamol N 500 ml intravenously per day rated of 10 infusions and low intensive laser therapy. Conducted therapy results in the dissolution of concrements, the normalization of purine metabolism, improvement of renal function, manifested by increasinf of glomerular filtration and decreasing of blood creatinine. Conclusion. It is reasonable to use Trometamol N in the complex therapy of urolithiasis in patients with gout, complicated by nephropathy.

About the authors

A V Annenkov

Peoples’Friendship University of Russia

Email: andre-annenkov@yandex.ru
Department of urology and operative nephrology

V P Avdoshin

Peoples’Friendship University of Russia

Email: Susya@kmail.ru
Department of urology and operative nephrology

M I Andryukhin

Peoples’Friendship University of Russia

Department of urology and operative nephrology

M N Israfilov

Peoples’Friendship University of Russia

Department of urology and operative nephrology

References

Statistics

Views

Abstract - 125

PDF (Russian) - 306

Cited-By



Copyright (c) 2013 Анненков А.В., Авдошин В.П., Андрюхин М.И., Исрафилов М.Н.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies